<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d312" origId="Nevirapine"><sentence id="DrugDDI.d312.s0" origId="s0" text="Nevirapine is principally metabolized by the liver via the cytochrome P450 isoenzymes, 3A4 and 2B6."><entity id="DrugDDI.d312.s0.e0" origId="s0.p0" charOffset="0-10" type="drug" text="Nevirapine"/><entity id="DrugDDI.d312.s0.e1" origId="s0.p4" charOffset="45-50" type="drug" text="liver"/><entity id="DrugDDI.d312.s0.e2" origId="s0.p5" charOffset="59-74" type="drug" text="cytochrome P450"/><pair id="DrugDDI.d312.s0.p0" e1="DrugDDI.d312.s0.e0" e2="DrugDDI.d312.s0.e1" interaction="false"/><pair id="DrugDDI.d312.s0.p1" e1="DrugDDI.d312.s0.e0" e2="DrugDDI.d312.s0.e2" interaction="true"/><pair id="DrugDDI.d312.s0.p2" e1="DrugDDI.d312.s0.e1" e2="DrugDDI.d312.s0.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s1" origId="s1" text="Nevirapine is known to be an inducer of these enzymes."><entity id="DrugDDI.d312.s1.e0" origId="s1.p9" charOffset="0-10" type="drug" text="Nevirapine"/></sentence><sentence id="DrugDDI.d312.s2" origId="s2" text="As a result, drugs that are metabolized by these enzyme systems may have lower than expected plasma levels when coadministered with nevirapine."><entity id="DrugDDI.d312.s2.e0" origId="s2.p17" charOffset="13-18" type="drug" text="drugs"/><entity id="DrugDDI.d312.s2.e1" origId="s2.p28" charOffset="132-142" type="drug" text="nevirapine"/><pair id="DrugDDI.d312.s2.p0" e1="DrugDDI.d312.s2.e0" e2="DrugDDI.d312.s2.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s3" origId="s3" text="The specific pharmacokinetic changes that occur with co-administration of nevirapine and other drugs are listed in CLINICAL PHARMACOLOGY, Table 1."><entity id="DrugDDI.d312.s3.e0" origId="s3.p33" charOffset="74-84" type="drug" text="nevirapine"/><entity id="DrugDDI.d312.s3.e1" origId="s3.p35" charOffset="95-100" type="drug" text="drugs"/><pair id="DrugDDI.d312.s3.p0" e1="DrugDDI.d312.s3.e0" e2="DrugDDI.d312.s3.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s4" origId="s4" text="Clinical comments about possible dosage modifications based on these pharmacokinetic changes are listed in Table 3."/><sentence id="DrugDDI.d312.s5" origId="s5" text="The data inTables 1 and 3 are based on the results of drug interaction studies conducted in HIV-1 seropositive subjects unless otherwise indicated."/><sentence id="DrugDDI.d312.s6" origId="s6" text="In addition to established drug interactions, there may be potential pharmacokinetic interactions between nevirapine and other drug classes that are metabolized by the cytochrome P450 system."><entity id="DrugDDI.d312.s6.e0" origId="s6.p65" charOffset="106-116" type="drug" text="nevirapine"/><entity id="DrugDDI.d312.s6.e1" origId="s6.p67" charOffset="127-131" type="drug" text="drug"/><entity id="DrugDDI.d312.s6.e2" origId="s6.p71" charOffset="168-183" type="drug" text="cytochrome P450"/><pair id="DrugDDI.d312.s6.p0" e1="DrugDDI.d312.s6.e0" e2="DrugDDI.d312.s6.e1" interaction="true"/><pair id="DrugDDI.d312.s6.p1" e1="DrugDDI.d312.s6.e0" e2="DrugDDI.d312.s6.e2" interaction="false"/><pair id="DrugDDI.d312.s6.p2" e1="DrugDDI.d312.s6.e1" e2="DrugDDI.d312.s6.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s7" origId="s7" text="These potential drug interactions are listed in Table 4."/><sentence id="DrugDDI.d312.s8" origId="s8" text="Although specific drug interaction studies in HIV-1 seropositive subjects have not been conducted for the classes of drugs listed in Table 4, additional clinical monitoring may be warranted when co-administering these drugs."><entity id="DrugDDI.d312.s8.e0" origId="s8.p85" charOffset="117-122" type="drug" text="drugs"/><entity id="DrugDDI.d312.s8.e1" origId="s8.p94" charOffset="218-223" type="drug" text="drugs"/><pair id="DrugDDI.d312.s8.p0" e1="DrugDDI.d312.s8.e0" e2="DrugDDI.d312.s8.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s9" origId="s9" text="The in vitro interaction between nevirapine and the antithrombotic agent warfarin is complex."><entity id="DrugDDI.d312.s9.e0" origId="s9.p96" charOffset="33-43" type="drug" text="nevirapine"/><entity id="DrugDDI.d312.s9.e1" origId="s9.p98" charOffset="52-72" type="drug" text="antithrombotic agent"/><pair id="DrugDDI.d312.s9.p0" e1="DrugDDI.d312.s9.e0" e2="DrugDDI.d312.s9.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s10" origId="s10" text="As a result, when giving these drugs concomitantly, plasma warfarin levels may change with the potential for increases in coagulation time."><entity id="DrugDDI.d312.s10.e0" origId="s10.p104" charOffset="31-36" type="drug" text="drugs"/><entity id="DrugDDI.d312.s10.e1" origId="s10.p105" charOffset="59-67" type="drug" text="warfarin"/><pair id="DrugDDI.d312.s10.p0" e1="DrugDDI.d312.s10.e0" e2="DrugDDI.d312.s10.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s11" origId="s11" text="When warfarin is co-administered with nevirapine, anticoagulation levels should be monitored frequently."><entity id="DrugDDI.d312.s11.e0" origId="s11.p112" charOffset="5-13" type="drug" text="warfarin"/><entity id="DrugDDI.d312.s11.e1" origId="s11.p115" charOffset="38-48" type="drug" text="nevirapine"/><pair id="DrugDDI.d312.s11.p0" e1="DrugDDI.d312.s11.e0" e2="DrugDDI.d312.s11.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s12" origId="s12" text="Table 3 Established Drug Interactions: Alteration in Dose or Regimen May Be Recommended Based on Drug Interaction Studies"/><sentence id="DrugDDI.d312.s13" origId="s13" text="Drug Name"><entity id="DrugDDI.d312.s13.e0" origId="s13.p132" charOffset="0-4" type="drug" text="Drug"/></sentence><sentence id="DrugDDI.d312.s14" origId="s14" text="Effect on Concentration of Nevirapine or Concomitant Drug"><entity id="DrugDDI.d312.s14.e0" origId="s14.p135" charOffset="27-37" type="drug" text="Nevirapine"/><entity id="DrugDDI.d312.s14.e1" origId="s14.p137" charOffset="53-57" type="drug" text="Drug"/><pair id="DrugDDI.d312.s14.p0" e1="DrugDDI.d312.s14.e0" e2="DrugDDI.d312.s14.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s15" origId="s15" text="Clinical Comment"/><sentence id="DrugDDI.d312.s16" origId="s16" text="Clarithromycin"><entity id="DrugDDI.d312.s16.e0" origId="s16.p139" charOffset="0-14" type="drug" text="Clarithromycin"/></sentence><sentence id="DrugDDI.d312.s17" origId="s17" text="? Clarithromycin ?14OH- clarithromycin"><entity id="DrugDDI.d312.s17.e0" origId="s17.p140" charOffset="2-16" type="drug" text="Clarithromycin"/></sentence><sentence id="DrugDDI.d312.s18" origId="s18" text="Clarithromycin exposure was significantly decreased by nevirapine;"><entity id="DrugDDI.d312.s18.e0" origId="s18.p141" charOffset="0-14" type="drug" text="Clarithromycin"/><entity id="DrugDDI.d312.s18.e1" origId="s18.p145" charOffset="55-65" type="drug" text="nevirapine"/><pair id="DrugDDI.d312.s18.p0" e1="DrugDDI.d312.s18.e0" e2="DrugDDI.d312.s18.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s19" origId="s19" text="however, 14-OH metabolite concentrations were increased.Because clarithromycin active metabolite has reduced activity against Mycobacteriumavium-intracellulare complex, overallactivity against this pathogen may bealtered."><entity id="DrugDDI.d312.s19.e0" origId="s19.p152" charOffset="64-78" type="drug" text="clarithromycin"/></sentence><sentence id="DrugDDI.d312.s20" origId="s20" text="Alternatives to clarithromycin,such as azithromycin, should be considered."><entity id="DrugDDI.d312.s20.e0" origId="s20.p161" charOffset="16-30" type="drug" text="clarithromycin"/><entity id="DrugDDI.d312.s20.e1" origId="s20.p162" charOffset="39-51" type="drug" text="azithromycin"/><pair id="DrugDDI.d312.s20.p0" e1="DrugDDI.d312.s20.e0" e2="DrugDDI.d312.s20.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s21" origId="s21" text="Efavirenz"><entity id="DrugDDI.d312.s21.e0" origId="s21.p166" charOffset="0-9" type="drug" text="Efavirenz"/></sentence><sentence id="DrugDDI.d312.s22" origId="s22" text="? Efavirenz"><entity id="DrugDDI.d312.s22.e0" origId="s22.p167" charOffset="2-11" type="drug" text="Efavirenz"/></sentence><sentence id="DrugDDI.d312.s23" origId="s23" text="Appropriate doses for this combination are not established."/><sentence id="DrugDDI.d312.s24" origId="s24" text="Ethinyl estradiol and Norethindrone"><entity id="DrugDDI.d312.s24.e0" origId="s24.p173" charOffset="0-17" type="drug" text="Ethinyl estradiol"/><entity id="DrugDDI.d312.s24.e1" origId="s24.p175" charOffset="22-35" type="drug" text="Norethindrone"/><pair id="DrugDDI.d312.s24.p0" e1="DrugDDI.d312.s24.e0" e2="DrugDDI.d312.s24.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s25" origId="s25" text="? Ethinyl estradiol  span class= c272 ?Norethindrone"><entity id="DrugDDI.d312.s25.e0" origId="s25.p176" charOffset="2-19" type="drug" text="Ethinyl estradiol"/></sentence><sentence id="DrugDDI.d312.s26" origId="s26" text="Oral contraceptives and other hormonalmethods of birth control should not be usedas the sole method of contraception inwomen taking nevirapine, since nevirapinemay lower the plasma levels of thesemedications."><entity id="DrugDDI.d312.s26.e0" origId="s26.p177" charOffset="0-19" type="drug" text="oral contraceptives"/><entity id="DrugDDI.d312.s26.e1" origId="s26.p180" charOffset="49-62" type="drug" text="birth control"/><entity id="DrugDDI.d312.s26.e2" origId="s26.p188" charOffset="132-142" type="drug" text="nevirapine"/><pair id="DrugDDI.d312.s26.p0" e1="DrugDDI.d312.s26.e0" e2="DrugDDI.d312.s26.e1" interaction="false"/><pair id="DrugDDI.d312.s26.p1" e1="DrugDDI.d312.s26.e0" e2="DrugDDI.d312.s26.e2" interaction="true"/><pair id="DrugDDI.d312.s26.p2" e1="DrugDDI.d312.s26.e1" e2="DrugDDI.d312.s26.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s27" origId="s27" text="An alternative or additional method of contraception is recommended."/><sentence id="DrugDDI.d312.s28" origId="s28" text="Fluconazole"><entity id="DrugDDI.d312.s28.e0" origId="s28.p200" charOffset="0-11" type="drug" text="Fluconazole"/></sentence><sentence id="DrugDDI.d312.s29" origId="s29" text="? Nevirapine"><entity id="DrugDDI.d312.s29.e0" origId="s29.p201" charOffset="2-12" type="drug" text="Nevirapine"/></sentence><sentence id="DrugDDI.d312.s30" origId="s30" text="Because of the risk of increased exposure tonevirapine, caution should be used inconcomitant administration, and patients should be monitored closely for nevirapine-associated adverse events."><entity id="DrugDDI.d312.s30.e0" origId="s30.p215" charOffset="154-164" type="drug" text="nevirapine"/></sentence><sentence id="DrugDDI.d312.s31" origId="s31" text="Indinavir"><entity id="DrugDDI.d312.s31.e0" origId="s31.p216" charOffset="0-9" type="drug" text="Indinavir"/></sentence><sentence id="DrugDDI.d312.s32" origId="s32" text="? Indinavir"><entity id="DrugDDI.d312.s32.e0" origId="s32.p217" charOffset="2-11" type="drug" text="Indinavir"/></sentence><sentence id="DrugDDI.d312.s33" origId="s33" text="Appropriate doses for this combination arenot established, but an increase in thedosage of indinavir may be required."><entity id="DrugDDI.d312.s33.e0" origId="s33.p225" charOffset="91-100" type="drug" text="indinavir"/></sentence><sentence id="DrugDDI.d312.s34" origId="s34" text="Ketoconazole"><entity id="DrugDDI.d312.s34.e0" origId="s34.p229" charOffset="0-12" type="drug" text="Ketoconazole"/></sentence><sentence id="DrugDDI.d312.s35" origId="s35" text="? Ketoconazole"><entity id="DrugDDI.d312.s35.e0" origId="s35.p230" charOffset="2-14" type="drug" text="Ketoconazole"/></sentence><sentence id="DrugDDI.d312.s36" origId="s36" text="Nevirapine and ketoconazole should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug."><entity id="DrugDDI.d312.s36.e0" origId="s36.p231" charOffset="0-10" type="drug" text="Nevirapine"/><entity id="DrugDDI.d312.s36.e1" origId="s36.p233" charOffset="15-27" type="drug" text="ketoconazole"/><entity id="DrugDDI.d312.s36.e2" origId="s36.p237" charOffset="88-100" type="drug" text="ketoconazole"/><entity id="DrugDDI.d312.s36.e3" origId="s36.p241" charOffset="153-157" type="drug" text="drug"/><pair id="DrugDDI.d312.s36.p0" e1="DrugDDI.d312.s36.e0" e2="DrugDDI.d312.s36.e1" interaction="true"/><pair id="DrugDDI.d312.s36.p1" e1="DrugDDI.d312.s36.e0" e2="DrugDDI.d312.s36.e2" interaction="false"/><pair id="DrugDDI.d312.s36.p2" e1="DrugDDI.d312.s36.e0" e2="DrugDDI.d312.s36.e3" interaction="false"/><pair id="DrugDDI.d312.s36.p3" e1="DrugDDI.d312.s36.e1" e2="DrugDDI.d312.s36.e2" interaction="false"/><pair id="DrugDDI.d312.s36.p4" e1="DrugDDI.d312.s36.e1" e2="DrugDDI.d312.s36.e3" interaction="false"/><pair id="DrugDDI.d312.s36.p5" e1="DrugDDI.d312.s36.e2" e2="DrugDDI.d312.s36.e3" interaction="false"/></sentence><sentence id="DrugDDI.d312.s37" origId="s37" text="Lopinavir/Ritonavir"><entity id="DrugDDI.d312.s37.e0" origId="s37.p242" charOffset="0-9" type="drug" text="Lopinavir"/><entity id="DrugDDI.d312.s37.e1" origId="s37.p243" charOffset="10-19" type="drug" text="Ritonavir"/><pair id="DrugDDI.d312.s37.p0" e1="DrugDDI.d312.s37.e0" e2="DrugDDI.d312.s37.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s38" origId="s38" text="? Lopinavir"><entity id="DrugDDI.d312.s38.e0" origId="s38.p244" charOffset="2-11" type="drug" text="Lopinavir"/></sentence><sentence id="DrugDDI.d312.s39" origId="s39" text="A dose increase of lopinavir/ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine."><entity id="DrugDDI.d312.s39.e0" origId="s39.p246" charOffset="19-28" type="drug" text="lopinavir"/><entity id="DrugDDI.d312.s39.e1" origId="s39.p247" charOffset="29-38" type="drug" text="ritonavir"/><entity id="DrugDDI.d312.s39.e2" origId="s39.p251" charOffset="109-119" type="drug" text="nevirapine"/><pair id="DrugDDI.d312.s39.p0" e1="DrugDDI.d312.s39.e0" e2="DrugDDI.d312.s39.e1" interaction="false"/><pair id="DrugDDI.d312.s39.p1" e1="DrugDDI.d312.s39.e0" e2="DrugDDI.d312.s39.e2" interaction="false"/><pair id="DrugDDI.d312.s39.p2" e1="DrugDDI.d312.s39.e1" e2="DrugDDI.d312.s39.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s40" origId="s40" text="Methadone"><entity id="DrugDDI.d312.s40.e0" origId="s40.p252" charOffset="0-9" type="drug" text="Methadone"/></sentence><sentence id="DrugDDI.d312.s41" origId="s41" text="? Methadonea"/><sentence id="DrugDDI.d312.s42" origId="s42" text="Methadone levels may be decreased;increased dosages may be required toprevent symptoms of opiate withdrawal.Methadone maintained patients beginningnevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly."><entity id="DrugDDI.d312.s42.e0" origId="s42.p254" charOffset="0-9" type="drug" text="Methadone"/><entity id="DrugDDI.d312.s42.e1" origId="s42.p264" charOffset="90-96" type="drug" text="opiate"/><pair id="DrugDDI.d312.s42.p0" e1="DrugDDI.d312.s42.e0" e2="DrugDDI.d312.s42.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s43" origId="s43" text="Nelfinavir"><entity id="DrugDDI.d312.s43.e0" origId="s43.p276" charOffset="0-10" type="drug" text="Nelfinavir"/></sentence><sentence id="DrugDDI.d312.s44" origId="s44" text="? Nelfinavir M8 Metabolite  span class= c272 ?NelfinavirCmin ?"><entity id="DrugDDI.d312.s44.e0" origId="s44.p277" charOffset="2-15" type="drug" text="Nelfinavir M8"/></sentence><sentence id="DrugDDI.d312.s45" origId="s45" text="The appropriate dose for nelfinavir incombination with nevirapine, with respectto safety and efficacy, has not been established."><entity id="DrugDDI.d312.s45.e0" origId="s45.p279" charOffset="25-35" type="drug" text="nelfinavir"/><entity id="DrugDDI.d312.s45.e1" origId="s45.p280" charOffset="55-65" type="drug" text="nevirapine"/><pair id="DrugDDI.d312.s45.p0" e1="DrugDDI.d312.s45.e0" e2="DrugDDI.d312.s45.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s46" origId="s46" text="Rifabutin"><entity id="DrugDDI.d312.s46.e0" origId="s46.p288" charOffset="0-9" type="drug" text="Rifabutin"/></sentence><sentence id="DrugDDI.d312.s47" origId="s47" text="?Rifabutin"/><sentence id="DrugDDI.d312.s48" origId="s48" text="Rifabutin and its metabolite concentrationswere moderately increased."><entity id="DrugDDI.d312.s48.e0" origId="s48.p290" charOffset="0-9" type="drug" text="Rifabutin"/><entity id="DrugDDI.d312.s48.e1" origId="s48.p292" charOffset="18-28" type="drug" text="metabolite"/><pair id="DrugDDI.d312.s48.p0" e1="DrugDDI.d312.s48.e0" e2="DrugDDI.d312.s48.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s49" origId="s49" text="Due to highintersubject variability, however, somepatients may experience large increases inrifabutin exposure and may be at higher riskfor rifabutin toxicity."/><sentence id="DrugDDI.d312.s50" origId="s50" text="Therefore, caution should be used in concomitant administration."/><sentence id="DrugDDI.d312.s51" origId="s51" text="Rifampin"><entity id="DrugDDI.d312.s51.e0" origId="s51.p311" charOffset="0-8" type="drug" text="Rifampin"/></sentence><sentence id="DrugDDI.d312.s52" origId="s52" text="? Nevirapine"><entity id="DrugDDI.d312.s52.e0" origId="s52.p312" charOffset="2-12" type="drug" text="Nevirapine"/></sentence><sentence id="DrugDDI.d312.s53" origId="s53" text="Nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug."><entity id="DrugDDI.d312.s53.e0" origId="s53.p313" charOffset="0-10" type="drug" text="Nevirapine"/><entity id="DrugDDI.d312.s53.e1" origId="s53.p315" charOffset="15-23" type="drug" text="rifampin"/><entity id="DrugDDI.d312.s53.e2" origId="s53.p319" charOffset="84-94" type="drug" text="nevirapine"/><entity id="DrugDDI.d312.s53.e3" origId="s53.p322" charOffset="146-150" type="drug" text="drug"/><pair id="DrugDDI.d312.s53.p0" e1="DrugDDI.d312.s53.e0" e2="DrugDDI.d312.s53.e1" interaction="true"/><pair id="DrugDDI.d312.s53.p1" e1="DrugDDI.d312.s53.e0" e2="DrugDDI.d312.s53.e2" interaction="false"/><pair id="DrugDDI.d312.s53.p2" e1="DrugDDI.d312.s53.e0" e2="DrugDDI.d312.s53.e3" interaction="false"/><pair id="DrugDDI.d312.s53.p3" e1="DrugDDI.d312.s53.e1" e2="DrugDDI.d312.s53.e2" interaction="false"/><pair id="DrugDDI.d312.s53.p4" e1="DrugDDI.d312.s53.e1" e2="DrugDDI.d312.s53.e3" interaction="false"/><pair id="DrugDDI.d312.s53.p5" e1="DrugDDI.d312.s53.e2" e2="DrugDDI.d312.s53.e3" interaction="false"/></sentence><sentence id="DrugDDI.d312.s54" origId="s54" text="Physicians needing to treatpatients co-infected with tuberculosis andusing a nevirapine containing regimen mayuse rifabutin instead."><entity id="DrugDDI.d312.s54.e0" origId="s54.p327" charOffset="77-87" type="drug" text="nevirapine"/></sentence><sentence id="DrugDDI.d312.s55" origId="s55" text="Saquinavir"><entity id="DrugDDI.d312.s55.e0" origId="s55.p328" charOffset="0-10" type="drug" text="Saquinavir"/></sentence><sentence id="DrugDDI.d312.s56" origId="s56" text="?Saquinavir"/><sentence id="DrugDDI.d312.s57" origId="s57" text="Appropriate doses for this combination arenot established, but an increase in thedosage of saquinavir may be required."><entity id="DrugDDI.d312.s57.e0" origId="s57.p337" charOffset="91-101" type="drug" text="saquinavir"/></sentence><sentence id="DrugDDI.d312.s58" origId="s58" text="aBased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and methadone concurrently, and evidence of decreased plasma concentrations of methadone."><entity id="DrugDDI.d312.s58.e0" origId="s58.p343" charOffset="21-29" type="drug" text="narcotic"/><entity id="DrugDDI.d312.s58.e1" origId="s58.p346" charOffset="75-85" type="drug" text="nevirapine"/><entity id="DrugDDI.d312.s58.e2" origId="s58.p348" charOffset="90-99" type="drug" text="methadone"/><entity id="DrugDDI.d312.s58.e3" origId="s58.p352" charOffset="165-174" type="drug" text="methadone"/><pair id="DrugDDI.d312.s58.p0" e1="DrugDDI.d312.s58.e0" e2="DrugDDI.d312.s58.e1" interaction="true"/><pair id="DrugDDI.d312.s58.p1" e1="DrugDDI.d312.s58.e0" e2="DrugDDI.d312.s58.e2" interaction="false"/><pair id="DrugDDI.d312.s58.p2" e1="DrugDDI.d312.s58.e0" e2="DrugDDI.d312.s58.e3" interaction="false"/><pair id="DrugDDI.d312.s58.p3" e1="DrugDDI.d312.s58.e1" e2="DrugDDI.d312.s58.e2" interaction="true"/><pair id="DrugDDI.d312.s58.p4" e1="DrugDDI.d312.s58.e1" e2="DrugDDI.d312.s58.e3" interaction="false"/><pair id="DrugDDI.d312.s58.p5" e1="DrugDDI.d312.s58.e2" e2="DrugDDI.d312.s58.e3" interaction="false"/></sentence><sentence id="DrugDDI.d312.s59" origId="s59" text="Table 4 ???????Potential Drug Interactions:Use With Caution, Dose Adjustment of Co-administered Drug May Be Needed due to Possible Decrease in Clinical Effect"><entity id="DrugDDI.d312.s59.e0" origId="s59.p360" charOffset="25-29" type="drug" text="Drug"/></sentence><sentence id="DrugDDI.d312.s60" origId="s60" text="Examples of Drugs in Which Plasma Concentrations May Be Decreased By Co-administration With Nevirapine"><entity id="DrugDDI.d312.s60.e0" origId="s60.p367" charOffset="12-17" type="drug" text="Drugs"/><entity id="DrugDDI.d312.s60.e1" origId="s60.p372" charOffset="92-102" type="drug" text="Nevirapine"/><pair id="DrugDDI.d312.s60.p0" e1="DrugDDI.d312.s60.e0" e2="DrugDDI.d312.s60.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s61" origId="s61" text="Drug Class Examples of Drugs"><entity id="DrugDDI.d312.s61.e0" origId="s61.p373" charOffset="0-4" type="drug" text="Drug"/><entity id="DrugDDI.d312.s61.e1" origId="s61.p374" charOffset="23-28" type="drug" text="Drugs"/><pair id="DrugDDI.d312.s61.p0" e1="DrugDDI.d312.s61.e0" e2="DrugDDI.d312.s61.e1" interaction="false"/></sentence><sentence id="DrugDDI.d312.s62" origId="s62" text="Antiarrhythmics"><entity id="DrugDDI.d312.s62.e0" origId="s62.p375" charOffset="0-15" type="drug" text="Antiarrhythmics"/></sentence><sentence id="DrugDDI.d312.s63" origId="s63" text="Amiodarone, disopyramide, lidocaine"><entity id="DrugDDI.d312.s63.e0" origId="s63.p376" charOffset="0-10" type="drug" text="Amiodarone"/><entity id="DrugDDI.d312.s63.e1" origId="s63.p377" charOffset="12-24" type="drug" text="disopyramide"/><entity id="DrugDDI.d312.s63.e2" origId="s63.p378" charOffset="26-35" type="drug" text="lidocaine"/><pair id="DrugDDI.d312.s63.p0" e1="DrugDDI.d312.s63.e0" e2="DrugDDI.d312.s63.e1" interaction="false"/><pair id="DrugDDI.d312.s63.p1" e1="DrugDDI.d312.s63.e0" e2="DrugDDI.d312.s63.e2" interaction="false"/><pair id="DrugDDI.d312.s63.p2" e1="DrugDDI.d312.s63.e1" e2="DrugDDI.d312.s63.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s64" origId="s64" text="Anticonvulsants"><entity id="DrugDDI.d312.s64.e0" origId="s64.p379" charOffset="0-15" type="drug" text="Anticonvulsants"/></sentence><sentence id="DrugDDI.d312.s65" origId="s65" text="Carbamazepine, clonazepam, ethosuximide"><entity id="DrugDDI.d312.s65.e0" origId="s65.p380" charOffset="0-13" type="drug" text="Carbamazepine"/><entity id="DrugDDI.d312.s65.e1" origId="s65.p381" charOffset="15-25" type="drug" text="clonazepam"/><entity id="DrugDDI.d312.s65.e2" origId="s65.p382" charOffset="27-39" type="drug" text="ethosuximide"/><pair id="DrugDDI.d312.s65.p0" e1="DrugDDI.d312.s65.e0" e2="DrugDDI.d312.s65.e1" interaction="false"/><pair id="DrugDDI.d312.s65.p1" e1="DrugDDI.d312.s65.e0" e2="DrugDDI.d312.s65.e2" interaction="false"/><pair id="DrugDDI.d312.s65.p2" e1="DrugDDI.d312.s65.e1" e2="DrugDDI.d312.s65.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s66" origId="s66" text="Antifungals"><entity id="DrugDDI.d312.s66.e0" origId="s66.p383" charOffset="0-11" type="drug" text="Antifungals"/></sentence><sentence id="DrugDDI.d312.s67" origId="s67" text="Itraconazole"><entity id="DrugDDI.d312.s67.e0" origId="s67.p384" charOffset="0-12" type="drug" text="Itraconazole"/></sentence><sentence id="DrugDDI.d312.s68" origId="s68" text="Calcium channel blockers"><entity id="DrugDDI.d312.s68.e0" origId="s68.p385" charOffset="0-24" type="drug" text="Calcium channel blockers"/></sentence><sentence id="DrugDDI.d312.s69" origId="s69" text="Diltiazem, nifedipine, verapamil"><entity id="DrugDDI.d312.s69.e0" origId="s69.p386" charOffset="0-9" type="drug" text="Diltiazem"/><entity id="DrugDDI.d312.s69.e1" origId="s69.p387" charOffset="11-21" type="drug" text="nifedipine"/><entity id="DrugDDI.d312.s69.e2" origId="s69.p388" charOffset="23-32" type="drug" text="verapamil"/><pair id="DrugDDI.d312.s69.p0" e1="DrugDDI.d312.s69.e0" e2="DrugDDI.d312.s69.e1" interaction="false"/><pair id="DrugDDI.d312.s69.p1" e1="DrugDDI.d312.s69.e0" e2="DrugDDI.d312.s69.e2" interaction="false"/><pair id="DrugDDI.d312.s69.p2" e1="DrugDDI.d312.s69.e1" e2="DrugDDI.d312.s69.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s70" origId="s70" text="Cancer chemotherapy"/><sentence id="DrugDDI.d312.s71" origId="s71" text="Cyclophosphamide"><entity id="DrugDDI.d312.s71.e0" origId="s71.p390" charOffset="0-16" type="drug" text="Cyclophosphamide"/></sentence><sentence id="DrugDDI.d312.s72" origId="s72" text="Ergot alkaloids"><entity id="DrugDDI.d312.s72.e0" origId="s72.p391" charOffset="0-15" type="drug" text="Ergot alkaloids"/></sentence><sentence id="DrugDDI.d312.s73" origId="s73" text="Ergotamine"><entity id="DrugDDI.d312.s73.e0" origId="s73.p392" charOffset="0-10" type="drug" text="Ergotamine"/></sentence><sentence id="DrugDDI.d312.s74" origId="s74" text="Immunosuppressants"><entity id="DrugDDI.d312.s74.e0" origId="s74.p393" charOffset="0-18" type="drug" text="Immunosuppressants"/></sentence><sentence id="DrugDDI.d312.s75" origId="s75" text="Cyclosporin, tacrolimus, sirolimus"><entity id="DrugDDI.d312.s75.e0" origId="s75.p394" charOffset="0-11" type="drug" text="Cyclosporin"/><entity id="DrugDDI.d312.s75.e1" origId="s75.p395" charOffset="13-23" type="drug" text="tacrolimus"/><entity id="DrugDDI.d312.s75.e2" origId="s75.p396" charOffset="25-34" type="drug" text="sirolimus"/><pair id="DrugDDI.d312.s75.p0" e1="DrugDDI.d312.s75.e0" e2="DrugDDI.d312.s75.e1" interaction="false"/><pair id="DrugDDI.d312.s75.p1" e1="DrugDDI.d312.s75.e0" e2="DrugDDI.d312.s75.e2" interaction="false"/><pair id="DrugDDI.d312.s75.p2" e1="DrugDDI.d312.s75.e1" e2="DrugDDI.d312.s75.e2" interaction="false"/></sentence><sentence id="DrugDDI.d312.s76" origId="s76" text="Motility agents"/><sentence id="DrugDDI.d312.s77" origId="s77" text="Cisapride"><entity id="DrugDDI.d312.s77.e0" origId="s77.p398" charOffset="0-9" type="drug" text="Cisapride"/></sentence><sentence id="DrugDDI.d312.s78" origId="s78" text="Opiate agonists"><entity id="DrugDDI.d312.s78.e0" origId="s78.p399" charOffset="0-15" type="drug" text="Opiate agonists"/></sentence><sentence id="DrugDDI.d312.s79" origId="s79" text="Fentanyl"><entity id="DrugDDI.d312.s79.e0" origId="s79.p400" charOffset="0-8" type="drug" text="Fentanyl"/></sentence><sentence id="DrugDDI.d312.s80" origId="s80" text="Examples of Drugs in Which Plasma Concentrations May Be Increased By Co-administration With Nevirapine"><entity id="DrugDDI.d312.s80.e0" origId="s80.p402" charOffset="12-17" type="drug" text="Drugs"/><entity id="DrugDDI.d312.s80.e1" origId="s80.p407" charOffset="92-102" type="drug" text="Nevirapine"/><pair id="DrugDDI.d312.s80.p0" e1="DrugDDI.d312.s80.e0" e2="DrugDDI.d312.s80.e1" interaction="true"/></sentence><sentence id="DrugDDI.d312.s81" origId="s81" text="Antithrombotics"/><sentence id="DrugDDI.d312.s82" origId="s82" text="Warfarin"><entity id="DrugDDI.d312.s82.e0" origId="s82.p409" charOffset="0-8" type="drug" text="Warfarin"/></sentence><sentence id="DrugDDI.d312.s83" origId="s83" text="Potential effect on anticoagulation."/><sentence id="DrugDDI.d312.s84" origId="s84" text="Monitoring of anticoagulation levels is recommended."/><sentence id="DrugDDI.d312.s85" origId="s85" text="Fat redistribution: Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and cushingoid appearance have been observed in patients receiving antiretroviral therapy."/><sentence id="DrugDDI.d312.s86" origId="s86" text="The mechanism and long-term consequences of these events are currently unknown."/><sentence id="DrugDDI.d312.s87" origId="s87" text="A causal relationship has not been established"/><sentence id="DrugDDI.d312.s88" origId="s88" text="."/><sentence id="DrugDDI.d312.s89" origId="s89" text="?"/></document>